Net Cash Provided by (Used in) Financing Activities of HeartSciences Inc. from 30 Apr 2022 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
HeartSciences Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Apr 2022 to 31 Jul 2025.
  • HeartSciences Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Jul 2025 was $3,648,314, a 561% increase year-over-year.
  • HeartSciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $2,733,632, a 74% decline from 2023.
  • HeartSciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $10,342,637, a 58% increase from 2022.
  • HeartSciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6,534,092, a 70% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

HeartSciences Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $3,648,314 +$3,096,631 +561% 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2025 Q1
Q2 2024 $551,683 +$227,321 +70% 01 May 2024 31 Jul 2024 10-Q 11 Sep 2025 2025 Q1
Q2 2023 $324,362 -$4,848,832 -94% 01 May 2023 31 Jul 2023 10-Q 12 Sep 2024 2025 Q1
Q2 2022 $5,173,194 01 May 2022 31 Jul 2022 10-Q 14 Sep 2023 2024 Q1

HeartSciences Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,733,632 -$7,609,005 -74% 01 May 2024 30 Apr 2025 10-K 24 Jul 2025 2025 FY
2023 $10,342,637 +$3,808,545 +58% 01 May 2023 30 Apr 2024 10-K 24 Jul 2025 2025 FY
2022 $6,534,092 +$2,693,237 +70% 01 May 2022 30 Apr 2023 10-K 29 Jul 2024 2024 FY
2021 $3,840,855 01 May 2021 30 Apr 2022 10-K 19 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.